Update on erythrodermic cutaneous T-cell lymphoma: Report of the international society for cutaneous lymphomas
Eric C. Vonderheid(Ashford and St Peter's Hospitals NHS Foundation Trust), Rein Willemze(Leiden University Medical Center), Madeleine Duvic(Cancer Clinic), L. Laroche(Centre Hospitalier de Luxembourg), Elise A. Olsen(Durham Technical Community College), Mark R. Pittelkow(Mayo Clinic in Arizona), Peter Heald(Yale University), Maria Grazia Bernengo(University of Turin), Günter Burg(Center for Pediatric Endocrinology Zurich), Masahiro Takigawa(Hamamatsu University), R. Russell‐Jones(St Thomas' Hospital)
Cited by 493
Related Papers
Treatment of Cutaneous T-Cell Lymphoma by Extracorporeal Photochemotherapy
|New England Journal of Medicine|1987|1.2k
Clinical End Points and Response Criteria in Mycosis Fungoides and Sézary Syndrome: A Consensus Statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer
|Journal of Clinical Oncology|2011|657
Pivotal Phase III Trial of Two Dose Levels of Denileukin Diftitox for the Treatment of Cutaneous T-Cell Lymphoma
|Journal of Clinical Oncology|2001|610